Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function

Journal of Hematology and Oncology

Volumn 1, Issue 1, 2008, Pages

  Chan, Wing Keung ^a   Cheung, Christopher Ching Hang ^a   Law, Helen Ka Wai ^a   Lau, Yu Lung ^a   Chan, Godfrey Chi Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; POLYSACCHARIDE;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DENDRITIC CELL; ENDOCYTOSIS; GANODERMA LUCIDUM; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKEMIA; MONOCYTE; T LYMPHOCYTE; TUMOR CELL LINE;

ADJUVANTS, IMMUNOLOGIC; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; ENDOCYTOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEUKEMIA; MONOCYTES; POLYSACCHARIDES; REISHI; T-LYMPHOCYTES;

EID: 77953049253     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-1-9     Document Type: Article

References (21)

1. Copeland DR, Silberberg Y, Pfefferbaum B: Attitudes and practices of families of children in treatment for cancer. A crosscultural study. Am J Pediatr Hematol Oncol 1983, 5(1):65-71. (Pubitemid 13102619)
2. Kelly KM, Jacobson JS, Kennedy DD, Braudt SM, Mallick M, Weiner MA: Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 2000, 22(5):412-416. (Pubitemid 33599747)
3. Sparber A, Wootton JC: Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies. J Altern Complement Med 2001, 7(3):281-287. (Pubitemid 32574902)
4. Ramsay NA, Kenny MW, Davies G, Patel JP: Complimentary and alternative medicine use among patients starting warfarin. Br J Haematol 2005, 130(5):777-780. (Pubitemid 43906651)
5. Chan G, Mullen P, Ha S, Wong G, Lee T, YL L: Use of alternative medical treatments in paediatric oncology patients in Hong Kong. Annual Scientific Meeting of the Paediactric Society of Hong Kong 1998.
6. Lin ZB, Zhang HN: Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 2004, 25(11):1387-1395.
7. Wasser SP, Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999, 19(1):65-96. (Pubitemid 29062102)
8. Berges C, Naujokat C, Tinapp S, Wieczorek H, Hoh A, Sadeghi M, Opelz G, Daniel V: A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun 2005, 333(3):896-907. (Pubitemid 40854243)
9. Kim KD, Choi SC, Noh YW, Kim JW, Paik SG, Yang Y, Kim KI, Lim JS: Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation. Exp Mol Med 2006, 38(1):72-84. (Pubitemid 43352436)
10. Cao LZ, Lin ZB: Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunology letters 2002, 83(3):163-169.
11. Chan WK, Lam DT, Law HK, Wong WT, Koo MW, Lau AS, Lau YL, Chan GC: Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med 2005, 11(6):1047-1057. (Pubitemid 43134054)
12. Lin YL, Liang YC, Lee SS, Chiang BL: Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. Journal of leukocyte biology 2005, 78(2):533-543.
13. Masterson AJ, Sombroek CC, De Gruijl TD, Graus YM, Vliet HJ van der, Lougheed SM, Eertwegh AJ van den, Pinedo HM, Scheper RJ: MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 2002, 100(2):701-703. (Pubitemid 34761140)
14. Lieu CW, Lee SS, Wang SY: The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 1992, 12(4):1211-1215.
15. Muller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP: Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 2006, 30(7):841-848. (Pubitemid 43816702)
16. Lu QY, Sartippour MR, Brooks MN, Zhang Q, Hardy M, Go VL, Li FP, Heber D: Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep 2004, 12(3):659-662.
17. Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, Ho NW: Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 2003, 9(4):491-497. (Pubitemid 37051539)
18. Buggins AG, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Thomas NS, Hirst WJ: Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001, 167(10):6021-6030. (Pubitemid 33062801)
19. Hsu HY, Hua KF, Lin CC, Lin CH, Hsu J, Wong CH: Extract of Reishi polysaccharides induces cytokine expression via TLR4modulated protein kinase signaling pathways. J Immunol 2004, 173(10):5989-5999. (Pubitemid 39487753)
20. Shao BM, Dai H, Xu W, Lin ZB, Gao XM: Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun 2004, 323(1):133-141. (Pubitemid 39200660)
21. Liu E, Law HK, Lau YL: BCG promotes cord blood monocytederived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. Pediatric research 2003, 54(1):105-112. (Pubitemid 36736814)